ReviewClinical Medicine Insights. Cardiology2015
Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy.
Review in Clinical Medicine Insights. Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Effect of Pulse Frequency on Shear-Induced Extension of Von Willebrand Factor in Continuous-Flow Ventricular Assist Device (CF-VAD).ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2026Article
- Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist Devices.Journal of cardiovascular development and disease · 2024Review
- Developments and Challenges in Durable Ventricular Assist Device Technology: A Comprehensive Review with a Focus on Advancements in China.Journal of cardiovascular development and disease · 2024Review
- Loss of pulsatility with continuous-flow left ventricular assist devices and the significance of the arterial endothelium in von-Willebrand factor production and degradation.Artificial organs · 2023Review
- Effect of pulsatility on shear-induced extensional behavior of Von Willebrand factor.Artificial organs · 2022Article
- A stable patient with a left ventricular assist device was admitted to the outpatient clinic with ventricular fibrillation.Anatolian journal of cardiology · 2021Article
- Ventricular Fibrillation 7 Years After Left Ventricular Assist Device Implantation.The American journal of case reports · 2020Article
- Clinical Approach to Manage Gastrointestinal Bleeding with a Left Ventricular Assist Device (LVAD).Cureus · 2019Review
- Past and Present of Total Artificial Heart Therapy: A Success Story.Medical science monitor basic research · 2015Review
- Heart Failure: An Exploration of Recent Advances in Research and Treatment (A).Clinical Medicine Insights. Cardiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure is epidemic in the United States with a prevalence of over 5 million. The diagnosis carries a mortality risk of 50% at 5 years rivaling many diagnoses of cancer. Heart transplantation, long the "gold standard" treatment for end stage heart failure unresponsive to maximal medical therapy falls way short of meeting the need with only about 2,000 transplants performed annually in the United States due to donor limitation. Left ventricular devices have emerged as a viable option for patients as both a "bridge to transplantation" and as a final "destination therapy".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.